ProQR R&D day Highlights Progress on Pipeline and Introduces Axiomer®, a novel proprietary RNA Technology Press release Key program features and updates: juin 15, 2017
ProQR Announces Results for the First Quarter of 2016 Press release LEIDEN, the Netherlands, May 18, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. mai 18, 2016
ProQR to Present Axiomer RNA Editing Platform Technology at RNA Editing Summit Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., April 04, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. avril 04, 2022
ProQR Announces Results for the Fourth Quarter and Full Year 2017 and Provides Business Update Press release Key updates février 28, 2018
ProQR Announces Presentations on Programs in Ophthalmology at Conferences in July Press release juillet 12, 2018
ProQR Appoints Thaddeus Dryja, M.D. to Scientific Advisory Board Press release Key Updates novembre 09, 2017
ProQR Appoints Peter A. Beal, PhD, as Chief ADAR Scientist Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 10, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. décembre 10, 2024
ProQR spins out Amylon Therapeutics as a privately-held company focused on central nervous system (CNS) therapeutics Press release Key updates septembre 12, 2017
ProQR Appoints ADAR Expert Dr. Peter A. Beal to Scientific Advisory Board to Focus on Axiomer® RNA A-to-I Editing Technology Press release Key Updates avril 10, 2018